Stay updated with breaking news from New Jersey Based Teligent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generic pharmaceutical company Teligent Inc. sought Chapter 11 protection in Delaware on Thursday with nearly $130 million in debt and plans for a sale, saying it has been dealing with "regulatory headwinds" and the impact of the COVID-19 pandemic.
Generic pharmaceutical company Teligent Inc. sought Chapter 11 protection in Delaware on Thursday with nearly $130 million in debt and plans for a sale, saying it has been dealing with "regulatory headwinds" and the impact of the COVID-19 pandemic.
(Bloomberg) -- Teligent Inc., a beleaguered generic drug maker, filed for court protection from creditors on Thursday with plans to sell itself. The publicly traded company listed assets of as much as $100 million and liabilities of as much as $500 million in its bankruptcy petition.